Showing all 8 results
Telmisartan & Atorvastatin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of both the hygroscopic ARB and the sensitive Statin.
Active Ingredient Strength Primary Clinical Function Telmisartan USP/Ph.Eur. 40 mg Standard ARB maintenance dose for continuous 24-hour peripheral vasodilation and RAAS blockade. Atorvastatin Calcium USP/Ph.Eur. 10 mg (Equivalent to Atorvastatin base) Standard initiation and maintenance dose for moderate-intensity LDL cholesterol reduction. Excipients Meglumine / Calcium Carbonate / Microcrystalline Cellulose / Magnesium Stearate Alkalizer for Telmisartan / Micro-environment stabilizer for Atorvastatin (Engineered for kinetic segregation) Telmisartan & Chlorthalidone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Bilayer or Matrix Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of both the hygroscopic ARB and the micro-dosed diuretic.
Active Ingredient Strength Primary Clinical Function Telmisartan USP/Ph.Eur. 40 mg Standard ARB maintenance dose for continuous 24-hour peripheral vasodilation and RAAS blockade. Chlorthalidone USP/Ph.Eur. 6.25 mg Highly precise, long-acting thiazide-like diuresis optimized for maximum safety and efficacy. Excipients Meglumine / Sodium Hydroxide / Microcrystalline Cellulose / Sodium Starch Glycolate Alkalizer for Telmisartan / Diluent / Superdisintegrant (Engineered for kinetic segregation and immediate dissolution) Telmisartan & Metoprolol Succinate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of both the hygroscopic ARB and the kinetic polymer matrix.
Active Ingredient Strength Primary Clinical Function Telmisartan USP/Ph.Eur. 50 mg Custom-titrated ARB dose for continuous 24-hour peripheral vasodilation and RAAS blockade. Metoprolol Succinate USP/Ph.Eur. 40 mg (Enteric-Coated / ER) Cardioselective beta-1 blockade for continuous heart rate control and anti-anginal defense. Excipients Meglumine / Methacrylic Acid Copolymer (Enteric Coat) / Microcrystalline Cellulose Alkalizer for Telmisartan / Gastric-resistant polymer for Metoprolol (Engineered for strict kinetic segregation) Telmisartan & Metoprolol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Bilayer Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of both the hygroscopic ARB and the kinetic polymer matrix.
Active Ingredient Strength Primary Clinical Function Telmisartan USP/Ph.Eur. 40 mg Standard ARB maintenance dose for continuous 24-hour peripheral vasodilation. Metoprolol Succinate USP/Ph.Eur. 25 mg (Extended-Release) Low-dose cardioselective beta-1 blockade for gentle heart rate control and initiation therapy. Excipients Meglumine / Hypromellose (HPMC) / Microcrystalline Cellulose / Sodium Hydroxide Alkalizer for Telmisartan / SR Polymer matrix for Metoprolol (Engineered for kinetic segregation) Telmisartan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips. The formulation utilizes specialized alkalizing agents to ensure the highly insoluble API rapidly dissolves in the gastrointestinal tract.
Active Ingredient Strength Primary Clinical Use Telmisartan USP/BP/Ph.Eur. 20 mg Initiation / Hepatic Impairment: Low-dose titration for sensitive or hepatically compromised patients. Telmisartan USP/BP/Ph.Eur. 40 mg Standard Global Dose: Once-daily maintenance therapy for essential hypertension. Telmisartan USP/BP/Ph.Eur. 80 mg Maximum CV Protection: High-dose therapy for severe hypertension and mandated cardiovascular risk reduction. Excipients Meglumine / Sodium Hydroxide / Povidone / Magnesium Stearate Alkalizing Stabilizer / Binder / Lubricant (Engineered to prevent API crystallization and ensure rapid absorption) Telmisartan, Amlodipine & Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Multi-Layer or Segregated Matrix Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the hygroscopic ARB and the sensitive CCB.
Active Ingredient Strength Primary Clinical Function Telmisartan USP/Ph.Eur. 40 mg Continuous 24-hour peripheral vasodilation and potassium-sparing RAAS blockade. Amlodipine Besylate USP/Ph.Eur. 5 mg (Equivalent to Amlodipine base) Calcium channel blockade for direct arterial relaxation and anti-anginal defense. Hydrochlorothiazide (HCTZ) USP/Ph.Eur. 12.5 mg Thiazide diuresis for blood volume reduction and mitigation of peripheral edema. Excipients Meglumine / Microcrystalline Cellulose / Sodium Starch Glycolate / Magnesium Stearate Alkalizer for Telmisartan / Diluent / Superdisintegrant (Engineered for kinetic segregation) *Pack Sizes: 10×10 or 10×15 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic cardiology adherence regimens).
Ticagrelor Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the highly sensitive active pharmaceutical ingredient across all global climate zones.
Active Ingredient Strength Primary Clinical Use Ticagrelor INN/Ph.Eur. 90 mg Acute & Post-ACS: Standard twice-daily dose for the first 12 months following a heart attack or stent placement. Ticagrelor INN/Ph.Eur. 60 mg Extended Maintenance: Long-term prophylaxis for high-risk patients continuing therapy beyond the initial 12-month period. Excipients Mannitol / Dibasic Calcium Phosphate / Sodium Starch Glycolate / Hypromellose Diluent / Superdisintegrant / Film Coating (Engineered for immediate, highly predictable gastric dissolution) Trimetazidine Tablets
FreeProduct Composition & Strength
We supply this product as an advanced Modified-Release (MR) Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the stability of both the active ingredient and the kinetic polymer matrix.
Active Ingredient Strength Primary Clinical Use Trimetazidine Dihydrochloride BP/Ph.Eur. 35 mg (Modified-Release) Global Standard: Twice-daily maintenance therapy for stable angina pectoris. Trimetazidine Dihydrochloride BP/Ph.Eur. 20 mg (Immediate-Release) Three-times-daily dosing for specialized dose titration or specific regional protocols. Excipients Hypromellose (HPMC) / Calcium Hydrogen Phosphate / Magnesium Stearate SR Polymer Matrix / Diluent / Lubricant (Engineered for strict 12-hour kinetic release)
